Author

Alyssa L. Kennedy

Dana-Farber/Boston Children's Cancer and Blood Disorders CenterORCID 0000-0001-7948-5933Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Bandana Sharma· 1 shared John A. Jr. PorcoiD· 1 shared Lauren E. BrowniD· 1 shared Marina P. VolegovaiD· 1 shared Rani E. GeorgeiD· 1 shared Ruben DriesiD· 1 shared Ushashi BanerjeeiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bandana Sharma

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The MYCN 5' UTR as a therapeutic target in neuroblastoma

Marina P. Volegova, Lauren E. Brown, Ushashi Banerjee, Ruben Dries, Bandana Sharma, Alyssa L. Kennedy, John A. Jr. Porco, Rani E. George

This study investigates the therapeutic potential of targeting eIF4A1 to inhibit MYCN expression in neuroblastoma by exploiting its role in translation of polypurine-rich 5' UTRs.

Cell Reports · Apr 23, 2024Peer-reviewedCancer Biology